Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Orthopedics · Familial Avascular Necrosis of the Femoral Head

Treatment Strategies and Surgery for FANFH

At a Glance

Treatment for Familial Avascular Necrosis of the Femoral Head (FANFH) depends on whether the hip bone has collapsed. Early stages may be treated with joint-preserving core decompression, while advanced stages typically require a total hip replacement to restore mobility.

Timely treatment is important to maximize your options for managing Familial Avascular Necrosis of the Femoral Head (FANFH). Because the condition is progressive, the goal of medical teams is to preserve your natural hip joint for as long as possible [1][2]. The strategy your doctor chooses depends almost entirely on whether the “ball” of your hip (the femoral head) is still round or has begun to flatten and collapse [3][4]. The timeline for disease progression is highly variable; for some patients, the femoral head may collapse over several months, while for others it may take years [4].

Conservative Management Before Surgery

While you are waiting for a surgical consultation or intervention, you will likely need to make adjustments to manage daily pain and protect the joint:

  • Weight-Bearing Restrictions: Doctors frequently recommend using crutches, a walker, or a cane to take weight off the affected hip, which may temporarily slow the progression of a collapse [2].
  • Pain Relief: Over-the-counter medications like acetaminophen or NSAIDs (non-steroidal anti-inflammatory drugs) are often used to manage daily discomfort, though you should discuss long-term NSAID use with your doctor [2].
  • Physical Therapy: Gentle range-of-motion exercises can help maintain joint mobility without putting excess strain on the hip [5].

Pre-Collapse: Joint-Preserving Strategies

If the disease is caught early—meaning the bone is dying but the structural shape of the hip is still intact—surgeons may attempt to save the joint.

  • Core Decompression: This is the most common joint-preserving procedure. A surgeon drills a small hole into the dead area of the bone to relieve internal pressure and “jumpstart” the healing process by allowing new blood vessels to grow [1][6].
  • Biological Augmentation: To increase the chances of success, doctors often add “boosters” during core decompression. This may include Bone Marrow Aspirate Concentrate (BMAC)—using your own concentrated cells to promote healing—or stem cells [7][8]. Research suggests that adding these biological materials may be more effective at reducing pain and delaying a full hip replacement than core decompression alone [8][9].
  • Surgical Risks: It is important to know that core decompression is not a cure and has a notable failure rate, particularly if the disease is advancing rapidly. The procedure may only delay, rather than prevent, the need for a hip replacement [5].

The Role of Medication

Patients often ask about “bone-strengthening” medications like bisphosphonates (e.g., alendronate) to prevent the hip from caving in. Currently, the evidence for these drugs in treating AVN is mixed [10]. Many large studies have found that bisphosphonates are not consistently effective at preventing femoral head collapse or the eventual need for surgery [10][11]. While they may be considered in very early stages, they are rarely used as a standalone solution for genetic conditions like FANFH [12][2].

Post-Collapse: Total Hip Arthroplasty (THA)

Once the femoral head has collapsed (often marked by a “crescent sign” on an MRI or X-ray), joint-preserving surgeries are no longer effective [13][14]. At this stage, Total Hip Arthroplasty (hip replacement) is the standard of care [15][3].

In the world of FANFH, it is common for patients to require a hip replacement in their 30s or 40s—decades earlier than the average patient [15][3].

  • Highly Successful Outcomes: Modern THA is highly successful. Young patients with osteonecrosis generally achieve excellent pain relief and return to high levels of activity [16][17].
  • Modern Materials: Surgeons often use ceramic bearing surfaces or advanced plastics (polyethylene) for younger patients because these materials are designed to last longer and withstand higher activity levels [18][19].
  • Longevity: Young patients can expect their hip replacement to last 15 to 20 years or more, though “revision” (a second surgery to replace worn parts) may eventually be necessary [20][17].
  • Surgical Risks: Like all major surgeries, THA carries risks, including infection, blood clots, nerve injury, and the potential for the new joint to dislocate [21].

Ultimately, whether through preservation or replacement, the goal is to keep you mobile and pain-free so you can continue your life without being defined by your diagnosis.

Common questions in this guide

What is the best treatment for FANFH before the hip collapses?
If the femoral head has not collapsed, joint-preserving surgery like core decompression is often recommended. This procedure involves drilling a small hole in the bone to relieve pressure and encourage new blood vessels to grow.
Can medications prevent the need for hip surgery in FANFH?
Medications like bisphosphonates are not consistently effective at preventing hip collapse or the eventual need for surgery. While they may be considered in very early stages, they are rarely used as a standalone solution for genetic conditions like FANFH.
Does adding stem cells or BMAC help with core decompression surgery?
Adding bone marrow aspirate concentrate (BMAC) or stem cells during core decompression may improve healing. Studies suggest these biological boosters can be more effective at reducing pain and delaying a hip replacement than core decompression alone.
What happens if my hip has already collapsed from FANFH?
Once the femoral head collapses, joint-preserving surgeries are no longer effective. At this stage, a total hip replacement is the standard of care to relieve pain and restore normal joint function.
How long does a hip replacement last for young patients with FANFH?
Young patients in their 30s or 40s can typically expect a modern hip replacement to last 15 to 20 years or more. Surgeons often use highly durable materials like ceramic to withstand higher activity levels, though a revision surgery may eventually be needed.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my imaging, am I still in the 'pre-collapse' window for joint-preserving surgery?
  2. 2.If we do core decompression, do you recommend augmenting it with bone marrow aspirate or stem cells to improve the success rate?
  3. 3.What is your experience performing total hip arthroplasty (THA) on patients in their 30s or 40s?
  4. 4.What type of 'bearing surface' (e.g., ceramic-on-ceramic) would you recommend for my age and activity level?
  5. 5.Given that my condition is genetic, is the success rate for joint-preserving surgery different than it would be for someone with injury-related AVN?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    Core Decompression for Osteonecrosis of the Femoral Head.

    Vega JF, Cervantes JE, Yee BF, Nho SJ

    Video journal of sports medicine 2026; (6(1)):26350254251368924 doi:10.1177/26350254251368924.

    PMID: 41674793
  2. 2

    Current concepts on osteonecrosis of the femoral head.

    Moya-Angeler J, Gianakos AL, Villa JC, et al.

    World journal of orthopedics 2015; (6(8)):590-601 doi:10.5312/wjo.v6.i8.590.

    PMID: 26396935
  3. 3

    Increasing trend toward joint-preserving procedures for hip osteonecrosis in the United States from 2010 to 2019.

    Ng MK, Kobryn A, Golub IJ, et al.

    Arthroplasty (London, England) 2023; (5(1)):23 doi:10.1186/s42836-023-00176-5.

    PMID: 37122010
  4. 4

    A new modification of the Trapdoor Procedure without surgical hip dislocation in the management of patients with osteonecrosis of the femoral head: A retrospective case series.

    Akman B, Güven M, Kadıoğlu B, et al.

    Acta orthopaedica et traumatologica turcica 2021; (55(4)):299-305 doi:10.5152/j.aott.2021.19276.

    PMID: 34464303
  5. 5

    Joint-preserving procedures for osteonecrosis of the femoral head.

    Atilla B, Bakırcıoğlu S, Shope AJ, Parvızı J

    EFORT open reviews 2019; (4(12)):647-658 doi:10.1302/2058-5241.4.180073.

    PMID: 32010453
  6. 6

    Minimally invasive core decompression with/without valgus intertrochanteric osteotomy for early-to-early-collapse avascular necrosis of the femoral head: A prospective case series.

    Mulyadi D, Mas'ud MS, Riantho A

    International journal of surgery case reports 2025; (134()):111821 doi:10.1016/j.ijscr.2025.111821.

    PMID: 40818397
  7. 7

    Osteonecrosis of the femoral head: treatment before the collapse. Experience with decompression and biological therapy.

    Lara-Taranchenko Y, Mimendia I, Barro V, et al.

    European journal of orthopaedic surgery & traumatology : orthopedie traumatologie 2025; (35(1)):145 doi:10.1007/s00590-025-04257-w.

    PMID: 40178687
  8. 8

    Core decompression isolated or combined with bone marrow-derived cell therapies for femoral head osteonecrosis.

    Migliorini F, Maffulli N, Eschweiler J, et al.

    Expert opinion on biological therapy 2021; (21(3)):423-430 doi:10.1080/14712598.2021.1862790.

    PMID: 33297783
  9. 9

    Combining autologous bone marrow buffy coat and angioconductive bioceramic rod grafting with advanced core decompression improves short-term outcomes in early avascular necrosis of the femoral head: a prospective, randomized, comparative study.

    Li Q, Liao W, Fu G, et al.

    Stem cell research & therapy 2021; (12(1)):354 doi:10.1186/s13287-021-02436-0.

    PMID: 34147125
  10. 10

    Necrotic-cell-activated macrophages drive an ERK-Bcl-xL survival pathway in osteoclasts and confer bisphosphonate resistance.

    Uehara K, Kato K, Tsuji S, et al.

    Biochemical and biophysical research communications 2026; (812()):153591 doi:10.1016/j.bbrc.2026.153591.

    PMID: 41825125
  11. 11

    Efficacy of bisphosphonates in the treatment of femoral head osteonecrosis: A PRISMA-compliant meta-analysis of animal studies and clinical trials.

    Li D, Yang Z, Wei Z, Kang P

    Scientific reports 2018; (8(1)):1450 doi:10.1038/s41598-018-19884-z.

    PMID: 29362430
  12. 12

    Effectiveness of Strontium Ranelate in the Treatment of Rat Model of Legg-Calve-Perthes Disease.

    Chen YP, Tan A, Ho WP, et al.

    Indian journal of orthopaedics 2018; (52(4)):380-386 doi:10.4103/ortho.IJOrtho_437_16.

    PMID: 30078896
  13. 13

    Bone Marrow Aspirate Concentrate in Combination With Intravenous Iloprost Increases Bone Healing in Patients With Avascular Necrosis of the Femoral Head: A Matched Pair Analysis.

    Pilge H, Bittersohl B, Schneppendahl J, et al.

    Orthopedic reviews 2016; (8(4)):6902 doi:10.4081/or.2016.6902.

    PMID: 28507661
  14. 14

    [Pedicled vascularized iliac bone graft for treatment of osteonecrosis of the femoral head].

    Asmus A, Vogel K, Vogel A, et al.

    Operative Orthopadie und Traumatologie 2020; (32(2)):127-138 doi:10.1007/s00064-020-00650-2.

    PMID: 32052100
  15. 15

    [Total hip replacement in avascular femoral head necrosis].

    Betsch M, Tingart M, Driessen A, et al.

    Der Orthopade 2018; (47(9)):751-756 doi:10.1007/s00132-018-3617-5.

    PMID: 30094647
  16. 16

    Total Hip Arthroplasty via direct anterior approach for osteonecrosis; comparison with primary hip osteoarthritis in a mid term follow up.

    Moharrami A, Mirghaderi SP, Marzban S, et al.

    Journal of clinical orthopaedics and trauma 2022; (34()):102042 doi:10.1016/j.jcot.2022.102042.

    PMID: 36263249
  17. 17

    Outcomes after total hip arthroplasty in young patients with osteonecrosis of the hip.

    Swarup I, Shields M, Mayer EN, et al.

    Hip international : the journal of clinical and experimental research on hip pathology and therapy 2017; (27(3)):286-292 doi:10.5301/hipint.5000457.

    PMID: 28165595
  18. 18

    Mid-term survivorship and clinical results of cementless total hip arthroplasty for steroid-induced avascular necrosis.

    Karatas ME, Kemah B, Soylemez MS, Saglam N

    Northern clinics of Istanbul 2024; (11(3)):219-224 doi:10.14744/nci.2023.38107.

    PMID: 39005747
  19. 19

    Outcomes of total hip arthroplasty in patients with osteonecrosis of the femoral head-a current review.

    Pierce TP, Elmallah RK, Jauregui JJ, et al.

    Current reviews in musculoskeletal medicine 2015; (8(3)):246-51 doi:10.1007/s12178-015-9283-x.

    PMID: 26045086
  20. 20

    Long-Term Survivorship of Total Hip Arthroplasty with Highly Cross-Linked Polyethylene for Osteonecrosis.

    Hart A, Janz V, Trousdale RT, et al.

    The Journal of bone and joint surgery. American volume 2019; (101(17)):1563-1568 doi:10.2106/JBJS.18.01218.

    PMID: 31483399
  21. 21

    Non-concentric Reduction Due to Entrapped Loose Bone Piece During a Single-stage Bilateral Total Hip Arthroplasty.

    Jain M, Sahoo SS, Sahu NK, et al.

    Cureus 2018; (10(12)):e3780 doi:10.7759/cureus.3780.

    PMID: 30854268

This page provides educational information about surgical and non-surgical treatments for FANFH. Always consult your orthopedic surgeon or healthcare provider to determine the best treatment plan for your specific hip condition.

Get notified when new evidence is published on Familial avascular necrosis of femoral head.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.